Comparing the effects of commercial to open initial specimen diversion techniques on clinical outcomes and institutional costs

View at publisher
Authors: Erin H. Yang, Corina Lopez, Sabra L. Shay, Margaret Reed, Victoria McArdle, Todd Michael Lasco, Bradley Lembcke, Mayar Al Mohajer
Cited by: 1
References: 9

Abstract

The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.

Fields of Study & Subjects

Bacterial Identification and Susceptibility Testing Blood transfusion and management Sepsis Diagnosis and Treatment

Publication details

Journal / source
Infection Control and Hospital Epidemiology
Publisher
Cambridge University Press (CUP)
Volume
47
Issue
5
Pages
526–529
Publication date
26 February 2026
Language
EN